Michael Vaughn
Family Medicine · Birmingham, ALNPI 1730249525
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $223 and has fallen 93.5% since, to $14 in 2024. That places this record below the midpoint for family medicine clinicians in AL, where the typical reported total is $638.
Across 44 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$144
- AbbVie$98
- Novo Nordisk$83
- Pfizer$72
- GSK$48
- Irhythm Technologies, Inc.$41
- plus $252 from 11 others
Across 190 payments — averaging $52,260 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$4.6M
- Ortho-clinical Diagnostics, Inc.$2.1M
- Abbott$1.3M
- Quidel Corporation$1M
- Romark Laboratories, LC$417K
- Sekisui Diagnostics LLC$181K
- plus $364K from 8 others
What the payments were for
- Food & beverage$738100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 8 | $144 |
| AbbVie | 6 | $98 |
| Novo Nordisk | 5 | $83 |
| Pfizer | 4 | $72 |
| GSK | 3 | $48 |
| Irhythm Technologies, Inc. | 2 | $41 |
| Dexcom, Inc. | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| AstraZeneca | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Seqirus USA Inc | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $11 |
How this compares
$738 in reported general payments places this provider in the 50th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Birmingham
- Lashelle BarmoreBirmingham$486K
- Scott WeisbergBirmingham$38K
- Regina BenjaminBayou la Batre$222K
- Jonathan ParkerMuscle Shoals$214K
- Kathleen DupperHuntsville$210K
- Whitney TewHuntsville$114K
- Kelly HunterTuscaloosa$84K
- Daniel EnglertHuntsville$82K
- Joel LaughlinMobile$75K
- Ashleigh Butts-WilkersonMobile$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.